Target intelligence / Profile preview

RNA, U6 small nuclear 903, pseudogene (RNU6-903P)

Target
RNU6-903P
Molecular classification
Other (pseudogene, non-coding RNA fragment)
01

Overview

RNA, U6 small nuclear 903, pseudogene (RNU6-903P) is a **processed pseudogene** corresponding to a U6 small nuclear RNA (snRNA) locus[3]. U6 snRNA itself is a core non-coding RNA of the spliceosomal complex, involved in pre-mRNA splicing[7]. RNU6-903P, however, **does not code for a functional RNA or protein product and does not participate directly or indirectly in any known molecular or disease mechanism**[1][3][5]. Pseudogenes like RNU6-903P typically represent disabled genomic copies of functional genes and are generally not considered therapeutic targets; they lack protein-coding capacity and do not encode receptor, transporter, enzyme, or other druggable classes[2][3]. There is no evidence that RNU6-903P has any known **biological function, disease association, therapeutic relevance, drug interactions, or recognized biomarker value**[1][2][3][5]. It is not a receptor or any other actionable molecular target for drug development. Assessment of correctness: This entry is **not a receptor, target, nor functional molecule** as used in therapeutic discovery or clinical biomarker applications. Pseudogenes are distinguished from genes by their lack of a functional product. Therefore, RNU6-903P should not be classified as a therapeutic target, nor is it relevant for drug mechanisms or disease pathways in current biomedical knowledge[2][3]. If you require structured data for genomic annotation, you may reference its HGNC ID (HGNC:47867)[3], but do not treat it as a valid target in therapeutic or diagnostic contexts.

Other names
RNU6-903PU6-903P

Beyond the preview

Go deeper on RNA, U6 small nuclear 903, pseudogene (RNU6-903P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 903, pseudogene (RNU6-903P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call